| ID | Name | CAS | Data |
Inp |
| 10-509-5 |
pyrrolidino[1,2-e]-4H-2,4-dimethyl-1,3,5-dithiazine
|
|
4 | 1462.00 |
| 12-207-8 |
2,6-Pyridinedicarboxylic acid, isobutyl 3-(2-methoxyethyl)nonyl ester
|
|
4 | 2795.00 |
| 13-737-9 |
Benzoic acid, 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]-, 1-methylethyl ester
|
|
4 | [2018.00; 2066.00] |
| 14-894-4 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTMS
|
|
4 | 2630.00 |
| 15-122-9 |
3-«alpha»,4-«xi»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 3464.00 |
| 15-718-8 |
5-«alpha»-Cholanoic acid, 3-«alpha»-12-«beta»-dihydroxy, methyl ester, TMS
|
|
4 | 3145.00 |
| 15-885-3 |
7-Oxo-3«alpha»-hydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | 3315.00 |
| 16-341-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-ethenyl-
|
2097-18-9 |
4 | 1522.00 |
| 16-602-5 |
3-«alpha»,6-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | [3224.00; 3282.00] |
| 16-907-7 |
8-Azabicyclo[3.2.1]octane-3,6-diol, diacetate (ester)
|
20399-48-8 |
4 | [1636.00; 1689.00] |
| 16-934-7 |
5«beta»-cholanoate,3«alpha»,7«alpha»-dihydroxy, methyl ester-trimethylsilyl ether
|
|
4 | 3210.00 |
| 17-776-2 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (20-O)-TBDMSi
|
|
4 | [3011.00; 3065.00] |
| 17-810-3 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 2670.00 |
| 18-493-5 |
2-Hydroxy-3-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 2142.00 |
| 18-902-0 |
3,6-Dioxa-2,7-disilaoctane, 2,2,4,7,7-pentamethyl-
|
17887-27-3 |
4 | [991.90; 1013.00] |
| 20-651-6 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»)-
|
7337-91-9 |
4 | [2452.00; 2515.00] |
| 21-343-7 |
2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-methoxy-
|
4025-80-3 |
4 | 1603.00 |
| 22-220-2 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, ethyl ester
|
|
4 | 2068.00 |
| 22-284-2 |
3«alpha»,7«alpha»-Dihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
4 | 3473.00 |
| 22-480-4 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-ethyl-
|
2097-16-7 |
4 | 1462.00 |
| 22-537-1 |
3«alpha»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 3339.00 |
| 22-683-9 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2-octyl ester
|
|
4 | 2437.00 |
| 22-711-7 |
Androst-5-en-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»)-
|
3747-91-9 |
4 | [2524.00; 2584.00] |
| 22-837-8 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«beta»,5«alpha»)-
|
57711-44-1 |
4 | [2816.00; 2870.00] |
| 23-363-3 |
21-Hydroxypregn-4-en-3,20-dione, 20,21-methylboronate
|
|
4 | 2935.00 |
| 23-577-6 |
5«alpha»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-92-4 |
4 | [2681.00; 2693.00] |
| 23-731-4 |
5-Pregnen-3«beta»-ol-20-one, tert-butyldimethylsilyl ether
|
|
4 | 3048.30 |
| 23-873-7 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
4867-14-5 |
4 | [2513.00; 2575.80] |
| 24-187-8 |
cis-5,8,11,14,17-Eicosapentaenoic acid, picolinyl ester
|
|
4 | 3132.10 |
| 24-360-5 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
1218-51-5 |
4 | [2020.00; 2060.00] |
| 25-279-5 |
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-
|
|
4 | 882.00 |
| 26-559-3 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)undecyloxy-
|
|
4 | 2300.00 |
| 26-843-7 |
20«beta»,21-Dihydroxypregn-4-en-3-one, 20,21-bis-TMS
|
|
4 | 3095.00 |
| 27-640-1 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)isohexyloxy-
|
|
4 | 1806.00 |
| 27-739-2 |
1-«beta»,3-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 3407.00 |
| 28-354-8 |
3«beta»-Hydroxy-7«alpha»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 3251.00 |
| 29-039-7 |
3«beta»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 3281.00 |
| 29-107-1 |
4-Isopropyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane
|
51486-55-6 |
4 | 1327.00 |
| 30-482-3 |
3-«beta»-Hydroxy-D-homo-5-androsten-17-one, TMS
|
|
4 | 2705.00 |
| 31-293-2 |
3«alpha»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 3384.00 |
| 31-743-2 |
2,6-Pyridinedicarboxylic acid, 2-chloro-6-fluorophenyl ethyl ester
|
|
4 | 2322.00 |
| 31-901-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate
|
|
4 | 2705.00 |
| 31-938-6 |
Phosphorothioic acid, O-(1,6-dihydro-6-oxo-1-phenyl-3-pyridazinyl) O,O-diethyl ester
|
119-12-0 |
4 | [2418.00; 2478.00] |
| 32-154-5 |
11B-Hydroxyandrosterone (5A-Androstan-3A,11B-diol-17-one), TMS
|
|
4 | 2696.00 |
| 32-281-4 |
6-Methyl-3,5-heptadien-2-one, PFBO # 1
|
|
4 | 1742.00 |
| 32-347-1 |
4-(3-Methyl-2-oxobutoxy)-7H-furo[3,2-g][1]benzopyran-7-one
|
5058-15-1 |
4 | [2525.00; 2535.70] |
| 32-486-7 |
4-Androsten-17«alpha»-ol-3-one (epitestosterone), MO-TMS
|
|
4 | 2600.00 |
| 32-504-6 |
7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-E][1,5]diazocin-6-one, dodecahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»,14a«beta»)]-
|
489-72-5 |
4 | [2067.00; 2075.00] |
| 32-595-6 |
Butyl ([1,1,3,3-tetramethyl-3-(pyridin-3-ylmethoxy)disiloxanyl]oxy)acetate
|
|
4 | 2076.00 |
| 32-602-7 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, ethyl ester
|
|
4 | 2292.00 |
| 32-834-0 |
8-Azabicyclo[3.2.1]octane, 3-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]-8-methyl-, endo-
|
604-51-3 |
4 | [2615.00; 2650.00] |
| 33-052-7 |
21-Hydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 3030.00 |
| 33-098-7 |
2H-1-Benzopyran-2-one, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-
|
495-02-3 |
4 | 2634.00 |
| 33-284-0 |
4-Methyl-N-((4-methyl-1-piperazinyl)carbonyl)-benzenesulfonamide, N-methyl-
|
|
4 | 2435.00 |
| 33-504-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-methyl-
|
2288-13-3 |
4 | 1387.00 |
| 34-052-6 |
2,6-Pyridinedicarboxylic acid, di(2-chloro-6-fluorophenyl) ester
|
|
4 | 3010.00 |
| 34-503-5 |
2-Dimethylamino-1-phenothiazin-10-yl-propan-1-one (from Secergan)
|
|
4 | 2310.00 |
| 35-066-0 |
3-«beta»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 3248.00 |
| 35-475-6 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»-diol, bis-TMS
|
|
4 | 2645.00 |
| 35-516-0 |
3«beta»-Hydroxy-7«beta»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 3319.00 |
| 35-612-3 |
5.beta.-Androstan-3.alpha.,11.beta.-diol-17-one (Androsterone), MO
|
|
4 | 2622.00 |
| 35-705-0 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,7-«alpha»-trihydroxy, methyl ester, TMS
|
|
4 | 3377.00 |
| 36-008-3 |
2-Acetamido-2-([(trimethylsilyl)oxy]methyl)propane-1,3-diyl diacetate
|
|
4 | 1763.00 |
| 36-739-2 |
17«alpha»-Methyl-17«beta»-hydroxy-1,4-androstadien-3-one, trimethylsilyl deriv.
|
41235-52-3 |
4 | [2732.00; 2828.00] |
| 37-043-3 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTBDMS
|
|
4 | 2930.00 |
| 37-814-7 |
Cholan-24-oic acid, 3,12-bis[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,12«alpha»)-
|
6818-41-3 |
4 | [3174.00; 3260.00] |
| 38-312-3 |
3-Hydroxy-2-phenyl-propionic acid 6-hydroxy-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester
|
|
4 | [2332.00; 2335.00] |
| 38-835-3 |
5-Hydroxyindole-3-acetic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 2682.60 |
| 39-235-8 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)hexyloxy-
|
|
4 | 1844.00 |
| 39-541-8 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 3165.00 |
| 39-674-1 |
3-.beta.,19-Dihydroxy-5-androsten-17-one, MO TMS
|
|
4 | 2705.00 |
| 39-938-8 |
3«alpha»,12«beta»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
4 | [3154.00; 3221.00] |
| 40-031-2 |
3-«beta»,12-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 3145.00 |
| 40-908-9 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one, O-trimethylsilyl
|
18880-80-3 |
4 | 2622.00 |
| 40-944-9 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, O-methyloxime, (17«beta»)-
|
56210-83-4 |
4 | [2634.00; 2712.00] |
| 41-139-2 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»,5«beta»)-
|
10426-96-7 |
4 | [2495.00; 2574.50] |
| 41-590-1 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTMS
|
|
4 | 2550.00 |
| 41-928-6 |
1,5-Pentanediamine, N-(6-methoxy-8-quinolinyl)-N'-(1-methylethyl)-
|
86-78-2 |
4 | [2540.00; 2555.00] |
| 42-130-0 |
Androst-4-en-17«alpha»-methyl-17«beta»-ol-3-one, TMS
|
|
4 | [2791.00; 2826.00] |
| 42-377-7 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS(d9)
|
|
4 | 3155.00 |
| 42-392-0 |
4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-
|
19103-54-9 |
4 | 3232.60 |
| 42-488-4 |
5-«alpha»-Pregnane-17-«alpha»,20-«alpha»-diol, bis-TMS
|
|
4 | 2675.00 |
| 42-492-9 |
5«beta»-Androstane-3,17-dione, mono-TMS, (2-en)
|
|
4 | [2497.00; 2510.00] |
| 42-738-6 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 17,20-methylboronate
|
|
4 | 2585.00 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3449.00 |
| 43-060-7 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, butyl ester
|
|
4 | 2267.00 |
| 43-393-8 |
(17«beta»)-2,3-Dimethoxy-17-[(trimethylsilyl)oxy]estra-1(10),2,4-triene
|
|
4 | 2817.60 |
| 43-867-2 |
5-(2-ethyl,5-methylheptanyl)-3-methyl-2H-pyran-2-one
|
|
4 | 1809.00 |
| 43-935-6 |
N-tert-Butyl-N'-acetyl-6-chloro-1,3,5-triazine-2,4-diamine
|
|
4 | 1898.00 |
| 44-110-0 |
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-N-[2-[(trimethylsilyl)oxy]ethyl]-
|
5630-81-9 |
4 | [1258.00; 1281.00] |
| 44-815-8 |
6-Chloro-N,N'-(cyclopropyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | [2048.58; 2086.66] |
| 45-216-2 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, TMS
|
|
4 | [2668.00; 2699.00] |
| 45-619-5 |
3-«alpha»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 3167.00 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3410.00 |
| 46-137-9 |
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-methylpropyl)-
|
|
4 | 1908.00 |
| 46-390-8 |
3«beta»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 3409.00 |
| 46-416-9 |
5«beta»-Androstan-3«alpha»-ol-11,17-dione, MO
|
|
4 | 2543.00 |
| 46-908-3 |
3«alpha»,7«beta»-Dihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
4 | [3376.00; 3405.00] |
| 47-380-8 |
3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 1
|
|
4 | 1986.00 |
| 49-242-9 |
5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile
|
|
4 | [2049.00; 2069.00] |
|
« Previous Results
Next Results »
|